Last checked at 
| Monday 27 February | |
| Associated British Foods PLC | Trading Statement |
| Beeks Financial Cloud Group PLC | Half Year Results |
| Bunzl PLC | Full Year Results |
| Centralnic Group PLC | Full Year Results |
| Dechra Pharmaceuticals PLC | Half Year Results |
| DX Group PLC | Half Year Results |
| GlobalData PLC | Full Year Results |
| Greencoat Renewables PLC | Full Year Results |
| Kosmos Energy Ltd | Full Year Results |
| Quartix Technologies PLC | Full Year Results |
| RHI Magnesita NV | Full Year Results |
| Senior PLC | Full Year Results |
| Tuesday 28 February | |
| abrdn PLC | Full Year Results |
| Benchmark Holdings PLC | Q1 Results |
| Bluefield Solar Income Fund Ltd | Half Year Results |
| boohoo Group PLC | Full Year Results |
| Cap-XX Ltd | Half Year Results |
| Croda International PLC | Full Year Results |
| Dalata Hotel Group PLC | Full Year Results |
| Derwent London PLC | Full Year Results |
| Hutchmed (China) Ltd | Full Year Results |
| Intertek Group PLC | Full Year Results |
| Kitwave Group PLC | Full Year Results |
| Man Group PLC | Full Year Results |
| McBride PLC | Half Year Results |
| Morgan Advanced Materials PLC | Full Year Results |
| Ocado Group PLC | Full Year Results |
| Princess Private Equity Holding Ltd | Full Year Results |
| Rotork PLC | Full Year Results |
| Serco Group PLC | Full Year Results |
| St James's Place PLC | Full Year Results |
| S-Ventures PLC | Full Year Results |
| Travis Perkins PLC | Full Year Results |
| Uniphar PLC | Full Year Results |
| Unite Group PLC | Full Year Results |
| Videndum PLC | Full Year Results |
| XP Power Ltd | Full Year Results |
| Wednesday 1 March | |
| Aston Martin Lagonda Global Holdings PLC | Full Year Results |
| Capital & Counties Properties PLC | Full Year Results |
| GetBusy PLC | Full Year Results |
| Glenveagh Properties PLC | Full Year Results |
| Global Invacom Group Ltd | Full Year Results |
| Haydale Graphene Industries PLC | Half Year Results |
| International Personal Finance PLC | Full Year Results |
| Nichols PLC | Full Year Results |
| Permanent TSB Group Holdings PLC | Full Year Results |
| Persimmon PLC | Full Year Results |
| Rathbones Group PLC | Full Year Results |
| Reckitt Benckiser Group PLC | Full Year Results |
| Ricardo PLC | Half Year Results |
| Weir Group PLC | Full Year Results |
| Thursday 2 March | |
| Alfa Financial Software Holdings PLC | Full Year Results |
| Apax Global Alpha Ltd | Full Year Results |
| Beazley PLC | Full Year Results |
| Brooks Macdonald Group PLC | Half Year Results |
| Cairn Homes PLC | Full Year Results |
| Capita PLC | Full Year Results |
| Capital & Regional PLC | Full Year Results |
| Coats Group PLC | Full Year Results |
| CRH PLC | Full Year Results |
| Flutter Entertainment PLC | Full Year Results |
| Funding Circle Holdings PLC | Full Year Results |
| Grafton Group PLC | Full Year Results |
| Haleon PLC | Full Year Results |
| Hunting PLC | Full Year Results |
| ITV PLC | Full Year Results |
| London Stock Exchange Group PLC | Full Year Results |
| Melrose Industries PLC | Full Year Results |
| Metro Bank PLC | Full Year Results |
| National Express Group PLC | Full Year Results |
| PPHE Hotel Group Ltd | Full Year Results |
| Schroder AsiaPacific Fund PLC | Full Year Results |
| Schroders PLC | Full Year Results |
| Spire Healthcare Group PLC | Full Year Results |
| Taylor Wimpey PLC | Full Year Results |
| Tritax Big Box REIT PLC | Full Year Results |
| Tyman PLC | Full Year Results |
| Vesuvius PLC | Full Year Results |
| Friday 3 March | |
| Avation PLC | Half Year Results |
| Faron Pharmaceuticals Ltd | Full Year Results |
| IMI PLC | Full Year Results |
| Pacific Horizon Investment Trust PLC | Half Year Results |
| Pearson PLC | Full Year Results |
| Rightmove PLC | Full Year Results |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. |
25 Aug 2021 11:43
Faron doses first patient in Covid-19 treatment trial
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Wednesday that the first patient has been dosed in the phase 2 and 3 'HIBISCUS' trial, assessing 'Traumakine', or intravenous interferon beta-1a, as a first-line treatment for hospitalised Covid-19 patients.
Read more